Wed, Oct 1, 2014, 1:47 AM EDT - U.S. Markets open in 7 hrs 43 mins

Recent

% | $
Quotes you view appear here for quick access.

Aethlon Medical, Inc. Message Board

  • eitzenschild eitzenschild Feb 22, 2014 4:31 PM Flag

    Need a catalyst or two

    If the exosome activity is not "near term" as Zacks suggests then we have only a few options in the spring:

    Hep C moves forward and partners need to be prominent
    Someone OTHER THAN Aethlon needs a good deal, a breakthrough or big publicity and we ride their wave. I don't see any other options.

    Some of us have asked the question before---is the only real driver cancer now? Wasn't there chatter about concussions and an announcement from the NFL during the Super Bowl? Sepsis? Sure there's a market for Hep C outside of the improved drugs coming out with Gilead, etc. but isn't the market much smaller now?

    The dilution of shares has to subside. 20% of the exosome subsidiary is now owned by someone else. I'd be interested in an alternative take on this view; shoot, I'd take some serious discussion about anything at this point.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AEMD
0.1215-0.0035(-2.80%)Sep 30 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Cyber-Ark Software Ltd.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT
eBay Inc.
NasdaqGSTue, Sep 30, 2014 4:15 PM EDT
Move, Inc.
NasdaqGSTue, Sep 30, 2014 4:00 PM EDT